New Zealand raises concerns with Elanco/Bayer
New Zealand’s competition watchdog is concerned that Elanco Animal Health’s €7 billion acquisition of Bayer’s animal health business could harm competition for the wholesale supply of several animal healthcare products.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10